Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial.

Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C.

JAMA. 1998 Nov 11;280(18):1596-600.

PMID:
9820262
2.

Effects of garcinia cambogia (Hydroxycitric Acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial.

Hayamizu K, Ishii Y, Kaneko I, Shen M, Okuhara Y, Shigematsu N, Tomi H, Furuse M, Yoshino G, Shimasaki H.

Curr Ther Res Clin Exp. 2003 Sep;64(8):551-67. doi: 10.1016/j.curtheres.2003.08.006.

3.

An overview of the safety and efficacy of a novel, natural(-)-hydroxycitric acid extract (HCA-SX) for weight management.

Preuss HG, Rao CV, Garis R, Bramble JD, Ohia SE, Bagchi M, Bagchi D.

J Med. 2004;35(1-6):33-48. Review.

PMID:
18084863
4.

Evaluation of the safety and efficacy of hydroxycitric acid or Garcinia cambogia extracts in humans.

Márquez F, Babio N, Bulló M, Salas-Salvadó J.

Crit Rev Food Sci Nutr. 2012;52(7):585-94. doi: 10.1080/10408398.2010.500551. Review.

PMID:
22530711
5.

IQP-GC-101 reduces body weight and body fat mass: a randomized, double-blind, placebo-controlled study.

Chong PW, Beah ZM, Grube B, Riede L.

Phytother Res. 2014 Oct;28(10):1520-6. doi: 10.1002/ptr.5158. Epub 2014 May 2.

6.

Evaluation of the pharmacotherapeutic efficacy of Garcinia cambogia plus Amorphophallus konjac for the treatment of obesity.

Vasques CA, Rossetto S, Halmenschlager G, Linden R, Heckler E, Fernandez MS, Alonso JL.

Phytother Res. 2008 Sep;22(9):1135-40. doi: 10.1002/ptr.2323.

PMID:
18729243
7.

Zonisamide for weight loss in obese adults: a randomized controlled trial.

Gadde KM, Franciscy DM, Wagner HR 2nd, Krishnan KR.

JAMA. 2003 Apr 9;289(14):1820-5.

PMID:
12684361
8.
10.

Efficacy of Slim339 in reducing body weight of overweight and obese human subjects.

Toromanyan E, Aslanyan G, Amroyan E, Gabrielyan E, Panossian A.

Phytother Res. 2007 Dec;21(12):1177-81.

PMID:
17639559
11.

Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control.

Preuss HG, Garis RI, Bramble JD, Bagchi D, Bagchi M, Rao CV, Satyanarayana S.

Int J Clin Pharmacol Res. 2005;25(3):133-44.

PMID:
16366421
12.

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.

Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M.

JAMA. 1999 Oct 27;282(16):1568-75.

PMID:
10546697
14.

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.

Davidson MH, Hauptman J, DiGirolamo M, Foreyt JP, Halsted CH, Heber D, Heimburger DC, Lucas CP, Robbins DC, Chung J, Heymsfield SB.

JAMA. 1999 Jan 20;281(3):235-42. Erratum in: JAMA 1999 Apr 7;281(13):1174.

PMID:
9918478
15.

A comprehensive scientific overview of Garcinia cambogia.

Semwal RB, Semwal DK, Vermaak I, Viljoen A.

Fitoterapia. 2015 Apr;102:134-48. doi: 10.1016/j.fitote.2015.02.012. Epub 2015 Feb 27. Review.

PMID:
25732350
16.

One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.

Finer N, James WP, Kopelman PG, Lean ME, Williams G.

Int J Obes Relat Metab Disord. 2000 Mar;24(3):306-13.

PMID:
10757623
17.

Effects of (-)-hydroxycitric acid on appetitive variables.

Mattes RD, Bormann L.

Physiol Behav. 2000 Oct 1-15;71(1-2):87-94.

PMID:
11134690
18.

The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.

Muls E, Kolanowski J, Scheen A, Van Gaal L; ObelHyx Study Group.

Int J Obes Relat Metab Disord. 2001 Nov;25(11):1713-21.

PMID:
11753595
19.

(-)-Hydroxycitric acid does not affect energy expenditure and substrate oxidation in adult males in a post-absorptive state.

Kriketos AD, Thompson HR, Greene H, Hill JO.

Int J Obes Relat Metab Disord. 1999 Aug;23(8):867-73.

PMID:
10490789
20.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
Items per page

Supplemental Content

Write to the Help Desk